Non-small cell lung cancer is the leading cause of cancer deaths globally and also in Latin America. Several treatment strategies are available, such as surgery and radiotherapy for early-stage disease, and chemotherapy, immunotherapy and targeted therapies for metastatic patients. The decision on which treatment is more appropriate for each patient depends on performance status, comorbidities, tumour staging, availability of resources, and risk of toxicities. A multidisciplinary approach involving medical oncologists, surgeons, radiation oncologists, respire-atory medicine specialists and palliative care doctors is essential for successful treatment of NSCLC. This chapter will discuss the main treatment strategies for NSCLC in Latin Americ...
peer reviewedAlready known as the first cause of mortality in men, non-small cell lung cancer (NSCLC...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
Concurrent chemotherapy and radiotherapy (cCRT) is considered the standard treatment of locally adva...
Objectives To describe patient characteristics, treatment patterns, and survival among Latin America...
Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income count...
ABSTRACTIn the present paper, the author reviews the non-small-cell lung cancer treatment by stages ...
Non-communicable diseases, including cancer, are overtaking infectious disease as the leading health...
Lung cancer is the deadliest cancer worldwide and is of particular concern for Latin America. Its ri...
According to the Pan American Health Organization, noncommunicable diseases, including cancer, are t...
Abstract Introduction Stage III non‐small‐cell lung cancer (NSCLC) management is challenging given t...
Oligometastatic non-small cell lung cancer (NSCLC) describes an intermediate stage of NSCLC between ...
Vanessa Karen de Sá,1,2 Juliano C Coelho,3 Vera Luiza Capelozzi,1 Sergio Jobim de Azevedo3 1D...
According to the Pan American Health Organization, noncommunicable diseases, including cancer, are t...
none9siLung cancer is the most common cancer in the world today, in terms of both incidence and mort...
Non-small cell lung cancer (NSCLC) is a type of lung cancer and presently a prominent cause for deat...
peer reviewedAlready known as the first cause of mortality in men, non-small cell lung cancer (NSCLC...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
Concurrent chemotherapy and radiotherapy (cCRT) is considered the standard treatment of locally adva...
Objectives To describe patient characteristics, treatment patterns, and survival among Latin America...
Non-small-cell lung cancer (NSCLC) is an increasing global challenge, especially in low-income count...
ABSTRACTIn the present paper, the author reviews the non-small-cell lung cancer treatment by stages ...
Non-communicable diseases, including cancer, are overtaking infectious disease as the leading health...
Lung cancer is the deadliest cancer worldwide and is of particular concern for Latin America. Its ri...
According to the Pan American Health Organization, noncommunicable diseases, including cancer, are t...
Abstract Introduction Stage III non‐small‐cell lung cancer (NSCLC) management is challenging given t...
Oligometastatic non-small cell lung cancer (NSCLC) describes an intermediate stage of NSCLC between ...
Vanessa Karen de Sá,1,2 Juliano C Coelho,3 Vera Luiza Capelozzi,1 Sergio Jobim de Azevedo3 1D...
According to the Pan American Health Organization, noncommunicable diseases, including cancer, are t...
none9siLung cancer is the most common cancer in the world today, in terms of both incidence and mort...
Non-small cell lung cancer (NSCLC) is a type of lung cancer and presently a prominent cause for deat...
peer reviewedAlready known as the first cause of mortality in men, non-small cell lung cancer (NSCLC...
The incidence of stage I and II nonsmall cell lung cancer is likely to increase with the ageing popu...
Concurrent chemotherapy and radiotherapy (cCRT) is considered the standard treatment of locally adva...